Cytokinetics Investor Relations Material
Latest events
Study Update
Cytokinetics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cytokinetics Inc
Access all reports
Cytokinetics Inc is a biopharmaceutical company focused on developing small-molecule therapies aimed at muscle function. The company targets diseases associated with impaired cardiac and skeletal muscle performance, including heart failure and neuromuscular disorders. Its operations include clinical development and research. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Cytokinetics Inc
Investor & Analyst Day 2024
Cytokinetics Inc
Study Update
Cytokinetics Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
CYTK
Country
🇺🇸 United States